Jeong Y. Sim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Antisense oligonucleotides targeting Ninjurin1 ameliorate the pathology of lead- and cadmium-induced chronic obstructive pulmonary disease in mice.
Journal: Respiratory research
Published: October 29, 2025
Stilbenoid gaylussacin modulates particulate matter-induced chromatin remodeling in macrophages to suppress chronic obstructive pulmonary disease.
Journal: Signal transduction and targeted therapy
Published: August 12, 2025
Gaylussacin, a stilbene glycoside, inhibits chronic obstructive pulmonary disease in mice.
Journal: Redox biology
Published: June 06, 2025
Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease.
Journal: Journal of hazardous materials
Published: July 26, 2023
RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.
Journal: The Journal of clinical investigation
Published: May 15, 2023
S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancer.
Journal: Clinical and translational medicine
Published: October 30, 2021
The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis.
Journal: Cancers
Published: June 02, 2020
RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.
Journal: The Journal of clinical investigation
Published: January 27, 2020
The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression.
Journal: Cancer research
Published: February 21, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026